Vaxart Inc Sustainability Reports
Vaxart, Inc. is a clinical-stage biotechnology company focused on the discovery and development of oral recombinant protein vaccines administered by tablet rather than injection.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG001S8PRQ4
3 reports from 2021 to 2024